<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02862756</url>
  </required_header>
  <id_info>
    <org_study_id>PR16021*</org_study_id>
    <nct_id>NCT02862756</nct_id>
  </id_info>
  <brief_title>Analysis of Thrombo-embolic Complications After Endovascular Treatment of Unruptured Intracranial Aneurysms</brief_title>
  <acronym>ACET</acronym>
  <official_title>Analysis of Thrombo-embolic Complications After Endovascular Treatment of Unruptured Intracranial Aneurysms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHU de Reims</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CHU de Reims</source>
  <brief_summary>
    <textblock>
      Endovascular treatment of ruptured and unruptured intracranial aneurysms presents&#xD;
      complications, mainly the thrombo-embolic complication. No specific studies have been&#xD;
      conducted to study factors associated with the occurrence of thromboembolic complications&#xD;
      (symptomatic or not) post endovascular treatment of intracranial aneurysms.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this multicenter, prospective study, patients with treatment of unruptured intracranial&#xD;
      aneurysms will be recruited. The thromboembolic complications will be research using&#xD;
      diffusion-weighted MRI.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 14, 2016</start_date>
  <completion_date type="Actual">March 9, 2021</completion_date>
  <primary_completion_date type="Actual">March 12, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Thromboembolic complication</measure>
    <time_frame>72 hours after endovascular treatment</time_frame>
    <description>Thromboembolic complication diagnosed using diffusion-weighted MRI</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">250</enrollment>
  <condition>Unruptured Intracranial Aneurysms</condition>
  <arm_group>
    <arm_group_label>patient with endovascular treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>diffusion-weighted MRI and clinical examination</intervention_name>
    <arm_group_label>patient with endovascular treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient having a programmed endovascular treatment for unruptured intracranial&#xD;
             aneurysm&#xD;
&#xD;
          -  patient older than 18 years&#xD;
&#xD;
          -  patient consenting to participate to the study&#xD;
&#xD;
          -  patient enrolled in the national healthcare insurance program&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with contraindications for MRI&#xD;
&#xD;
          -  patients whose clinical condition does not allow sufficient cooperation to the&#xD;
             realization of MRI&#xD;
&#xD;
          -  patients with arteriovenous malformation intracranial&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Chu de Reims</name>
      <address>
        <city>Reims</city>
        <zip>51092</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>August 8, 2016</study_first_submitted>
  <study_first_submitted_qc>August 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2016</study_first_posted>
  <last_update_submitted>May 12, 2021</last_update_submitted>
  <last_update_submitted_qc>May 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intracranial Aneurysm</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

